539 related articles for article (PubMed ID: 29861152)
1. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
2. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
3. Effect of a change in third party reimbursement rate on prescription gross margin.
Ganther JM; Kreling DH
J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
[TBL] [Abstract][Full Text] [Related]
4. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
Carroll NV
J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
[TBL] [Abstract][Full Text] [Related]
5. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
Carroll NV; Rupp MT; Holdford DA
J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
[TBL] [Abstract][Full Text] [Related]
6. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
7. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
Kreling DH; Kirk KW
Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
[TBL] [Abstract][Full Text] [Related]
8. Negotiating with third party payers: one community pharmacy's experience.
Fridy K; DeHart RM; Monk-Tutor MR
J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
11. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
Herrier RN; Spencer JR; Davis CD
J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a $4 generic drug program in a 340B pharmacy.
Bright DR; Adams AJ; Akala FO; Lengel AJ; Martin SJ; Powers MF
Am J Health Syst Pharm; 2010 Jun; 67(11):929-31. PubMed ID: 20484217
[TBL] [Abstract][Full Text] [Related]
13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
14. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
15. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
Pauly NJ; Brown JD
J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
[TBL] [Abstract][Full Text] [Related]
17. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
18. Profitability, third-party reimbursement, and access to community pharmacies.
Carroll NV; Miederhoff PA; Waters LW
Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
[TBL] [Abstract][Full Text] [Related]
19. Undocumented source of pharmacy benefit manager revenue.
Siracuse MV; Clark BE; Garis RI
Am J Health Syst Pharm; 2008 Mar; 65(6):552-7. PubMed ID: 18319501
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prescription reimbursement methodologies in Japan and the United States.
Akaho E; MacLaughlin EJ; Takeuchi Y
J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
